BE837741A - Polypeptides synthetiques et leur utilisation dans le diagnostic et le traitement de sclerose multiple - Google Patents

Polypeptides synthetiques et leur utilisation dans le diagnostic et le traitement de sclerose multiple

Info

Publication number
BE837741A
BE837741A BE163657A BE163657A BE837741A BE 837741 A BE837741 A BE 837741A BE 163657 A BE163657 A BE 163657A BE 163657 A BE163657 A BE 163657A BE 837741 A BE837741 A BE 837741A
Authority
BE
Belgium
Prior art keywords
diagnosis
treatment
multiple sclerosis
synthetic polypeptides
polypeptides
Prior art date
Application number
BE163657A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837741A publication Critical patent/BE837741A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE163657A 1975-01-20 1976-01-20 Polypeptides synthetiques et leur utilisation dans le diagnostic et le traitement de sclerose multiple BE837741A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54217575A 1975-01-20 1975-01-20

Publications (1)

Publication Number Publication Date
BE837741A true BE837741A (fr) 1976-05-14

Family

ID=24162652

Family Applications (1)

Application Number Title Priority Date Filing Date
BE163657A BE837741A (fr) 1975-01-20 1976-01-20 Polypeptides synthetiques et leur utilisation dans le diagnostic et le traitement de sclerose multiple

Country Status (8)

Country Link
US (1) US4113858A (fr)
BE (1) BE837741A (fr)
CA (1) CA1092600A (fr)
CH (1) CH614698A5 (fr)
FR (1) FR2297633A1 (fr)
GB (1) GB1528336A (fr)
IL (1) IL48862A (fr)
ZA (1) ZA76308B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230696A (en) * 1972-12-14 1980-10-28 St. Luke's Hospital Polypeptides useful for the purpose of treating multiple sclerosis
EP0000252B1 (fr) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, compositions pharmaceutiques les contenant et procédé de préparation de ces peptides
DE2860579D1 (en) * 1977-09-07 1981-04-23 Sandoz Ag Polypeptides, their preparation and pharmaceutical compositions containing them
SE446866B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis
US4331145A (en) * 1981-01-28 1982-05-25 Arthur Winter Multiple sclerosis treatment
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
US6252040B1 (en) * 1991-10-22 2001-06-26 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
DE4211878C2 (de) * 1992-04-09 1995-04-20 Ralf Dr Med Kluge Mittel zur Behandlung der Multiplen Sklerose
EP0674661B1 (fr) * 1992-12-18 2003-07-02 Molecular Rx., Inc. Titrage et traitement destines aux maladies demyelinisantes telles que la sclerose en plaques
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7057057B2 (en) 2002-05-22 2006-06-06 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US8034777B2 (en) * 2004-09-23 2011-10-11 Receptopharm, Inc. Modified anticholinergic neurotoxins as modulators of the autoimmune reaction
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH427842A (de) * 1960-07-29 1967-01-15 Ciba Geigy Verfahren zur Herstellung neuer Polypeptide
FR1310534A (fr) * 1961-07-26 1962-11-30 Ciba Geigy Procédé de préparation de nouveaux polypeptides, notamment du nonadécapeptide de formule l-séryl-l-tyrosyl-l-séryl-l-(chi)-l-glutaminyl-l-histidyl-l-phénylalanyl-l-arginyl-l-tryptophyl-glycyl-l-lysyl-l-prolyl-l-valvyl-glycyl-l-lysyl-l-lysyl-l-arginyl-l-arginyl-l-proline
GB1053177A (fr) * 1961-05-04
NL278010A (fr) * 1961-05-04 1900-01-01
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US3941162A (en) * 1974-03-28 1976-03-02 Uniroyal Inc. Reinforcing fabric for belts

Also Published As

Publication number Publication date
CH614698A5 (fr) 1979-12-14
FR2297633A1 (fr) 1976-08-13
GB1528336A (en) 1978-10-11
IL48862A (en) 1980-12-31
IL48862A0 (en) 1976-03-31
ZA76308B (en) 1977-01-26
CA1092600A (fr) 1980-12-30
US4113858A (en) 1978-09-12
FR2297633B1 (fr) 1979-02-23

Similar Documents

Publication Publication Date Title
BE837741A (fr) Polypeptides synthetiques et leur utilisation dans le diagnostic et le traitement de sclerose multiple
BE877394A (fr) Phenethanolamines et leur utilisation therapeutique
BE850312A (fr) Appareil pour le traitement de la peau
IL48690A0 (en) Blood compatible polymers and their use
BE873981A (fr) 9-amino et imino-dibenzopyrannes et leur utilisation therapeutique
FR2301590A1 (fr) Utilisation de perfluoroalcane-sulfonamides et/ou de
BE793389A (fr) Composes de phenylenediamine-s-triazine et leur utilisation
BE860606A (fr) Alliages de nickel-mischmetal-calcium et leur utilisation
BE785702A (fr) Produits de revetement de formes medicamenteuses et leur utilisation
FR2404629B1 (fr) Nouveaux tetrapeptides et leur utilisation therapeutique
BE794602A (fr) Alliages de nickel-chrome et leur utilisation
BE837665A (fr) Catalyseur contenant du rhodium et son utilisation dans la preparation de 1' -6-desoxy-5-tetracycline
BE779443A (fr) Biscarbamates de n-acyle, leur preparation et leur utilisation
LU80719A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE837279A (fr) Caoutchoucs chlorobutyles ameliores et leur emploi
BE803492A (fr) Perfectionnements aux catalyseurs de metaux du groupe du platine et leur utilisation
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE771463A (fr) Preparation d'halogeno-hydroxy-6-pyridone-2, et leur utilisation
FR2278682A1 (fr) Perhydrates d'ethanetetracarboxylates et leur utilisation dans des formulations de detergent
FR2336368A1 (fr) Chlorures de perfluoroalkyl-acetyle et leur preparation
BE865770A (fr) Esters d'acides 1,2-halogenhydrine-carboxylique leur preparation et leur utilisation dans la preparation de cyclopropane-carbaldehydes
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique
BE848914A (fr) Carbamate-sulfenyl-carbamoyl fluorures, leur preparation et leur emploi
BE809341A (fr) Adamantane-carboxylates de steroides et leur emploi

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ST.LUKE S HOSPITAL

Effective date: 19860131